A 37-year-old female was admitted with a 3-month history of fatigue, progressive exertion dyspnoea and left shoulder pain. Chest X-ray revealed a large pulmonary process in the left hemi-thorax. One month before she underwent cardiac catheterisation, and severe pulmonary arterial hypertension was diagnosed with a mean pulmonary artery pressure of 75 mmHg. There were no signs of coronary or valvular heart disease.
Pulmonary function tests showed a severe restrictive pattern (TLC 2.6 l; [56% predicted]), but capillary blood gases were normal (pCO 2 5.8 kPa, pO 2 10.3 kPa). Diffusion capacity was impaired, with a transfer factor for carbon monoxide of 53% predicted, consistent with restrictive lung disease. Pulmonary scintigraphy showed a highly reduced perfusion of the left lung with a distribution of 8% on the left and 92% on the right lung, but no signs of pulmonary embolism.
Thoracic MRI revealed a 10´7´5cm lesion extending to the pericardium, the diaphragm and the thoracic wall without signs of in ltration (Fig. 1 ).
There were no focal lesions detected on abdominal ultrasound, bronchoscopy, skeletal scintigraphy and liver MRI.
Ultrasound-guided transthoracic biopsy of the tumour revealed a malignant sarcoma.
The patient underwent left pneumonectomy with partial resection of the diaphragm and the pericardium due to tumour adhesion. Intraoperatively, a patent ductus Botalli (PDA) was found and subsequently occluded.
Histology revealed a pleomorphic myogenic sarcoma of the lung neither in ltrating the pleura nor metastasising into the hilar or mediastinal lymph Fig. 2 ). Immunohistology was positive for vimentin, desmin, a -sarcomere actin and anti-muscle actin and negative for a -smooth muscle actin. The proliferation rate was nearly 60%. A germline p53 mutation was excluded by automated sequencing of exons 4-10 of the TP 53 gene (ABI 377, Perkin-Elmer®). Chromosomal analysis of peripheral blood revealed an abnormal karyotype with a mosaic 45,X/46,XX,t(1;13)(p36;q14) /46,XX, consistent with a cytogenetic variant of Turner syndrome.
The further hospital stay was without complications. One month postoperatively, pulmonary artery pressure had decreased to 60 mmHg by echocardiography. At 2-year follow-up, the patient remained stable without radiological signs of recurrence of the tumour. Pulmonary artery pressure further decreased to 35 mmHg by echocardiography.
Discussion
Rhabdomyosarcoma is a typical extracranial solid malignant tumour presenting during childhood. Every year, approximately 250 cases are diagnosed in the United States. In Germany, 60-70 cases are found annually with an incidence of 0.5%. 2, 3 An intrathoracic manifestation of RMS is very rare. 4 Surgical resection is the only curative therapy. Radiation therapy is indicated in microscopic or residual disease, whereas chemotherapy is suggested for cytoreduction and eradication of micrometastases. Multimodality treatment protocols, used in clinical studies, enable disease-free survival up to 70%, in cases with incomplete resection. 2, 5 At recurrence of the sarcoma, 5-year survival is 40% for stage I versus 3% for any higher stage. 6 In our patient, radiation therapy of inoperable sarcoma during childhood induced complete remission and cure from the malignant disease for 36 years. 7 At the reoccurrence of the myosarcoma the patient presented with localized disease. The tumour was completely resected, and there was no indication for further anticancer therapy. Left pneumonectomy was feasible despite the impaired pulmonary function, because the left lung contributed only 8% to pulmonary blood ow and oxygenation. 8 However, there A. Localized tumour, gross total resection, but with microscopic residual disease. B. Locally extensive tumour (spread to regional lymph nodes), completely resected. C. Locally extensive tumour (spread to regional lymph nodes), gross total resection, but microscopic residual disease. III A. Localized or locally extensive tumour, gross residual disease after biopsy only. B. Localized or locally extensive tumour, gross residual disease after major resection (50% debulking). IV A. Any size primary tumour, with or without regional lymph node involvement, with distant metastases, irrespective of surgical approach to primary tumour. 1 1 1 was a considerable perioperative risk because of the severe pulmonary arterial hypertension. Surgical closure of the PDA was feasible after exclusion of an Eisenmenger syndrome resulting in a postoperative reduction of the pulmonary artery pressure.
We regard the present tumour as a re-occurrence of a similar tumour type in a high-risk constellation rather than a relapse after 36 years. Myosarcomas have a high local recurrence rate, and both the recent and the childhood tumour showed close histological similarities. Furthermore, chromosomal analysis was consistent with a variant of Turner syndrome. This condition is associated with a higher rate of nongonadal malignancies. 9, 10 Our Turner syndromeaffected patient had the following clinical anomalies: short in stature (155 cm), primary infertility, heart defect (persistent ductus Botalli), hypoplastic left hemi-thorax and mammary gland. There were no signs like epicanthal folds, low nuchal hair line, shield-like chest, webbed neck, high arched palate, renal anomalies, pigmented nevi or lymphedema.
The previous radiation therapy could also be regarded as a risk factor for developing a secondary malignancy. 11, 12 However, a p53 germline mutation, often found in early childhood mesenchymal tumours, was not present in our patient.
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Conclusion
We report the successful lung resection of a re-occurring pulmonary myosarcoma in a patient with Turner syndrome. A previous radiation therapy resulted in a complete remission for 36 years. The condition of an earlier myosarcoma, previous radiation therapy, and Turner syndrome has to be regarded as a high risk constellation for a secondary malignancy.
